ShaneWyattRauMDPhD, DFAPA(He/Him)

PubMed

• 43 citations
  A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
  L. Fredrik Jarskog, Cort A. Pedersen, Jacqueline L. Johnson, Robert M. Hamer, Shane W. Rau
  Schizophrenia Research. 2017-07-01
• 15 citations
  A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
  Anne C. Kelly, Brian Sheitman, Robert M. Hamer, David C. Rhyne, Robin M. Reed
  Journal of Clinical Psychopharmacology. 2014-08-01
• 148 citations
  Intranasal Oxytocin Blocks Alcohol Withdrawal in Human Subjects
  Cort A. Pedersen, Kelly L. Smedley, Jane Leserman, Lars Fredrik Jarskog, Shane W. Rau
  Alcoholism, Clinical and Experimental Research. 2013-03-01

Lectures

• Population Health Management-Part 2: The case for developing a population health management program 
  Array Behavioral Care - Clinician Community Event - 2/13/2024
• Population Health Management Part I: Caseload Management Strategies 
  Clinician Community Event - Array Behavioral Care - 6/20/2023
• A Paradigm Shift: The Evolving Concepts of Innovation and Integration in Telebehavioral Health 
  APA Annual Meeting 2023 - 5/24/2023
• Metabolic Syndrome and Mental Health 
  Clinician Community Event - Array Behavioral Care - 8/15/2021
• Join now to see all